<section id ="1036598-1309739" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2017, c. 6, s. 57(E)</h2></header><div class="modal-body"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><ul class="Section ProvisionList" id="1036598"><li><p class="Subsection amending" id="1036601"><strong><a class="sectionLabel" id="s-57"><span class="sectionLabel">57</span></a></strong> <span class="lawlabel">(1)</span> Paragraph 101(1)(d) of the English version of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(d)</span> specifying factors for the purposes of subsection 85(1) or (2), including factors relating to the introductory price of any medicine to which a patented invention, or invention protected by a certificate of supplementary protection, pertains;</p></li></ul></div></section></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><p class="Subsection amending" id="1036603"><span class="lawlabel">(2)</span> Paragraph 101(1)(h) of the English version of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(h)</span> requiring or authorizing the Board to perform the duties, in addition to those provided for in this Act, that are specified in the regulations, including duties to be performed by the Board in relation to the introductory price of any medicine to which a patented invention, or invention protected by a certificate of supplementary protection, pertains; and</p></li></ul></div></section></li></ul></div></section>